# Vivid Seats Inc.: financial statements, quarterly

SEAT · Nasdaq · CIK 1856031 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/seat.md) · [Financials](/companies/seat/financials.md) · [Filings](/companies/seat/filings.md) · [Insiders](/companies/seat/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/seat/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [154](/filings/0000950170-24-122768.md) | [167 d](/filings/0001193125-26-103023.md) | [160](/filings/0000950170-25-063944.md) | [170](/filings/0000950170-25-102376.md) | [153](/filings/0001193125-25-267993.md) | [165 d](/filings/0001193125-26-103023.md) | [134](/filings/0001193125-26-204975.md) | [114](/filings/0001193125-26-331507.md) | [105](/filings/0001193125-25-267993.md) | [97.5 d](/filings/0001193125-26-103023.md) | [97.5](/filings/0001193125-26-204975.md) | [104](/filings/0001193125-26-331507.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [6.7](/filings/0000950170-23-059732.md) | [7.7 d](/filings/0001193125-26-103023.md) | [12.9](/filings/0000950170-25-063944.md) | [(0.4)](/filings/0000950170-25-102376.md) | [10.6](/filings/0001193125-25-267993.md) | [(9.6) d](/filings/0001193125-26-103023.md) | [(10.6)](/filings/0000950170-25-063944.md) | [(335)](/filings/0000950170-25-102376.md) | [(30.2)](/filings/0001193125-25-267993.md) | [1,182 d](/filings/0001193125-26-103023.md) | [(14.6)](/filings/0001193125-26-204975.md) | [(14.3) d](/filings/0001193125-26-331507.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.94)](/filings/0001193125-26-204975.md) | not reported | not reported | not reported | [(1.35)](/filings/0001193125-26-204975.md) | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: not reported
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [269](/filings/0000950170-23-059732.md) | [125](/filings/0000950170-25-037612.md) | [154](/filings/0000950170-24-053932.md) | [234](/filings/0000950170-24-091203.md) | [202](/filings/0000950170-24-122768.md) | [243](/filings/0001193125-26-103023.md) | [199](/filings/0000950170-25-063944.md) | [153](/filings/0000950170-25-102376.md) | [145](/filings/0001193125-25-267993.md) | [103](/filings/0001193125-26-331507.md) | [144](/filings/0001193125-26-204975.md) | [137](/filings/0001193125-26-331507.md) |
| Current assets | $m | [406](/filings/0000950170-23-059732.md) | [246](/filings/0000950170-25-037612.md) | [297](/filings/0000950170-24-053932.md) | [371](/filings/0000950170-24-091203.md) | [326](/filings/0000950170-24-122768.md) | [345](/filings/0001193125-26-103023.md) | [320](/filings/0000950170-25-063944.md) | [265](/filings/0000950170-25-102376.md) | [234](/filings/0001193125-25-267993.md) | [178](/filings/0001193125-26-331507.md) | [243](/filings/0001193125-26-204975.md) | [249](/filings/0001193125-26-331507.md) |
| Total assets | $m | [1,385](/filings/0000950170-23-059732.md) | [1,550](/filings/0000950170-25-037612.md) | [1,589](/filings/0000950170-24-053932.md) | [1,655](/filings/0000950170-24-091203.md) | [1,611](/filings/0000950170-24-122768.md) | [1,636](/filings/0001193125-26-103023.md) | [1,606](/filings/0000950170-25-063944.md) | [1,149](/filings/0000950170-25-102376.md) | [1,107](/filings/0001193125-25-267993.md) | [637](/filings/0001193125-26-331507.md) | [692](/filings/0001193125-26-204975.md) | [689](/filings/0001193125-26-331507.md) |
| Current liabilities | $m | [454](/filings/0000950170-23-059732.md) | [488](/filings/0000950170-25-037612.md) | [525](/filings/0000950170-24-053932.md) | [470](/filings/0000950170-24-091203.md) | [413](/filings/0000950170-24-122768.md) | [426](/filings/0001193125-26-103023.md) | [416](/filings/0000950170-25-063944.md) | [367](/filings/0000950170-25-102376.md) | [348](/filings/0001193125-25-267993.md) | [303](/filings/0001193125-26-331507.md) | [371](/filings/0001193125-26-204975.md) | [379](/filings/0001193125-26-331507.md) |
| Total liabilities | $m | not reported | [963](/filings/0000950170-25-037612.md) | not reported | not reported | not reported | [1,022](/filings/0001193125-26-103023.md) | [999](/filings/0000950170-25-063944.md) | [803](/filings/0000950170-25-102376.md) | [772](/filings/0001193125-25-267993.md) | [722](/filings/0001193125-26-331507.md) | [787](/filings/0001193125-26-204975.md) | [794](/filings/0001193125-26-331507.md) |
| Long-term debt | $m | [266](/filings/0000950170-23-059732.md) | [265](/filings/0000950170-25-037612.md) | [264](/filings/0000950170-24-053932.md) | [387](/filings/0000950170-24-091203.md) | [386](/filings/0000950170-24-122768.md) | [385](/filings/0001193125-26-103023.md) | [386](/filings/0000950170-25-063944.md) | [385](/filings/0000950170-25-102376.md) | [384](/filings/0001193125-25-267993.md) | [383](/filings/0001193125-26-331507.md) | [383](/filings/0001193125-26-204975.md) | [382](/filings/0001193125-26-331507.md) |
| Shareholders' equity | $m | [(120)](/filings/0000950170-23-059732.md) | [105](/filings/0000950170-25-037612.md) | [140](/filings/0000950170-24-053932.md) | [156](/filings/0000950170-24-091203.md) | [329](/filings/0000950170-24-122768.md) | [261](/filings/0001193125-26-103023.md) | [381](/filings/0000950170-25-063944.md) | [217](/filings/0000950170-25-102376.md) | [272](/filings/0001193125-25-267993.md) | [(85.1)](/filings/0001193125-26-331507.md) | [(95.4)](/filings/0001193125-26-204975.md) | [(105)](/filings/0001193125-26-331507.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.7 d](/filings/0000950170-24-122768.md) | [32.9 d](/filings/0001193125-26-103023.md) | [39.2](/filings/0000950170-25-063944.md) | [(13.8) d](/filings/0000950170-25-102376.md) | [(19.2) d](/filings/0001193125-25-267993.md) | [47.8 d](/filings/0001193125-26-103023.md) | [(25.3)](/filings/0001193125-26-204975.md) | [(28.6) d](/filings/0001193125-26-331507.md) | [0.5 d](/filings/0001193125-25-267993.md) | [(38.2) d](/filings/0001193125-26-103023.md) | [46.0](/filings/0001193125-26-204975.md) | [(0.8) d](/filings/0001193125-26-331507.md) |
| Capital expenditure | $m | [0.2 d](/filings/0000950170-24-122768.md) | [0.1 d](/filings/0001193125-26-103023.md) | [0.1](/filings/0000950170-25-063944.md) | [0.3 d](/filings/0000950170-25-102376.md) | [0.4 d](/filings/0001193125-25-267993.md) | [3.5 d](/filings/0001193125-26-103023.md) | [1.8](/filings/0001193125-26-204975.md) | [0.2 d](/filings/0001193125-26-331507.md) | [0.0 d](/filings/0001193125-25-267993.md) | [0.1 d](/filings/0001193125-26-103023.md) | [0.0](/filings/0001193125-26-204975.md) | [0.0 d](/filings/0001193125-26-331507.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122768.md) | [12.5 d](/filings/0001193125-26-103023.md) | [3.1](/filings/0000950170-25-063944.md) | [17.0 d](/filings/0000950170-25-102376.md) | [2.9 d](/filings/0001193125-25-267993.md) | [(0.0) d](/filings/0001193125-26-103023.md) | [6.0](/filings/0001193125-26-204975.md) | [9.9 d](/filings/0001193125-26-331507.md) | [2.4 d](/filings/0001193125-25-267993.md) | [0.0 d](/filings/0001193125-26-103023.md) | [0.0](/filings/0001193125-26-204975.md) | [0.0 d](/filings/0001193125-26-331507.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2025 (2025-03-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [198](/filings/0000950170-22-008705.md) | [79.3](/filings/0000950170-22-015752.md) | [82.0](/filings/0000950170-22-022883.md) | [10.5](/filings/0001193125-26-204975.md) | [10.8](/filings/0001193125-26-204975.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,241,195 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001193125-26-331507.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.